Sphingosine kinase 2 (SPHK2) can activate HDAC through the production of S1P, leading to histone H3K9 deacetylation and epigenetic remodeling of PASMCs, thereby promoting PAH vascular remodeling. This evidence concerns the gene SPHK2 and pulmonary arterial hypertension.